gene synthesis blockchain platform
OUR GOAL IS TO DEVELOP INSTRUMENTS THAT GREATLY ENHANCE RESEARCH EFFORTS RELATED TO BIOLOGICAL DISCOVERY, DIAGNOSTICS, AND THERAPEUTICS
The ability to synthesize long stretches of DNA would greatly augment molecular biology research. Currently, non-templated synthesis of nucleic acids at the gene scale is usually conducted by outsource providers at very high costs with prolonged production times. The cost and time constraints commonly result in developing an alternative study design that limits the number of experimental conditions that can be reasonably tested.
Global Synthetic Biology Market is witnessing an increase in growth, owing to the potential of the technology to change the society. The increasing support from government and private institutions, increasing R&D investments. However, years of bio-safety & security regulations have stifled tech development in gene synthesis and resulted in supply shortages.
Our proposal is to build a blockchain-based IoT ecosystem and portable gene-synthesizing device that will allow investigators to synthesize long stretches of DNA of any sequence on demand in a cost-effective, simple, and short time-frame.
Our key advantage is in the solving of biosecurity and scalability issues, what our competitors are facing. We are creating a regulated database where all pathogens are immutably recorded in a decentralised and fully-auditable manner, which protects from hacking, data manipulation and fraud. Screening rules are encoded as smart contracts. Based on the requested DNA sequence of synthetic gene, contracts will self-execute and potentially dangerous sequences will be identified and blocked before a synthesis process is started.
We believe the successful implementation of our blockchain-based biosecurity platform will facilitate the potential of gene synthesis technologies while mitigating risks of abuse.
The Pathogens Repository component of the Biosecurity Platform manages a distributed database for pathogen-specific data that is built on top of a programmable blockchain (Ethereum) and distributed file system (IPFS). Key properties of the Pathogens Repository include transparency, immutability and capacity.
The second component of the Biosecurity Platform is the Screening Protocol. This portion of the platform is used to define screening rules that can be directly evaluated against the Pathogens Repository. It is important that internationally coordinated regulators create a set of well-defined, designed and tested screening contracts which are publically available on the blockchain. The requirements defined by regulators will be critical to applications monitoring gene synthesis requests in the ecosystem.
PORTABLE GENE-SYNTHESIZING DEVICE
Our solution is a “cheap” (as compared to current world market of DNA synthesis devices) portable device that is designed to synthesize gene from an idea to a test-tube for extremely low price. Think of it as being a huge robotic-based extensive and very expensive equipment that has been condensed down to the size of a computer. Device is based on combination of oligonucleotide synthesizer and high-throughput gene assembly module. We are working hard on the system architecture with assumption that it will be mapped to microfluidic technologies in the future releases.
ADVANCED OPTIMIZATION STRATEGIES
Be the first to receive the latest SynTau news, events and product updates.
+375 29 996-06-23